ISSN: 1520-765X

Journal Home

Journal Guideline

European Heart Journal, Supplement Q3 Unclaimed

Oxford University Press United Kingdom

Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

European Heart Journal, Supplement is a journal indexed in SJR in Cardiology and Cardiovascular Medicine with an H index of 41. It has an SJR impact factor of 0,477 and it has a best quartile of Q3. It is published in English. It has an SJR impact factor of 0,477.

Type: Journal

Type of Copyright:

Languages: English

Open Access Policy:

Type of publications:

Publication frecuency: -

Categories: Cardiology and Cardiovascular Medicine (Q3)

Price

- €

Inmediate OA

NPD

Embargoed OA

- €

Non OA

Metrics

0,477

SJR Impact factor

41

H Index

97

Total Docs (Last Year)

398

Total Docs (3 years)

3011

Total Refs

593

Total Cites (3 years)

389

Citable Docs (3 years)

1.3

Cites/Doc (2 years)

31.04

Ref/Doc

Comments

No comments ... Be the first to comment!

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID *

* The email or ORCID field is only to validate the authenticity of the comment, the identity will not be public. .

Other journals with similar parameters

Journal of Geriatric Cardiology Q3
Cardiovascular Engineering and Technology Q3
Phlebology Q3
Thrombosis Q3
Cardiovascular Revascularization Medicine Q3

Compare this journals

Aims and Scope

Best articles by citations

Arrhythmia substrate and management in hypertrophic cardiomyopathy: from molecules to implantable card ioverter-defibrillators

Diabetology for cardiologists

Future role of electrical therapy for atrial fibrillation: reality for all?

Genetic factors in atherosclerosis: status and perspectives

Dietary omega-3 fatty acids and human growth factor and cytokine gene expression

Improving outcomes through statin therapy ? a review of ongoing trials

Myocardial metabolism: the diabetic heart

Reducing low-density lipoprotein cholesterol ? treating to target and meeting new European goals

The complementary role of drug, ablation and device in the electrical therapy of atrial fibrillation

The unstable plaque

The relationship between the endothelium and the vessel wall

Diabetes and the heart: compromised myocardial function ? a common challenge

SHOW MORE ARTICLES

Reflections on the Diet and Reinfarction Trial (DART)

Bringing VALUE to LIFE

Evaluation of myocardial viability after myocardial infarction

The metabolic syndrome ? a growing problem

Introduction

Effects of consistent atrial pacing and atrial rate stabilization - two pacing algorithms to suppress recurrent paroxysmal atrial fibrillation in brady-tachy syndrome

Foreword

Perspectives on n-3 PUFAs: primary prevention, antiarrhythmic effects, congestive heart failure

Oxidative stress, the renin-angiotensin system, and atherosclerosis

Feasibility and possible cost-effectiveness of contrast echocardiography in the emergency room for the evaluation of chest pain syndromes

Lessons from GRACE: the Global Registry of Acute Coronary Events

Myocardial reperfusion injury